Pulmatrix Stock Analysis

Pulmatrix Stock Analysis Notes

The company has price-to-book ratio of 0.44. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pulmatrix recorded a loss per share of 3.87. The entity last dividend was issued on the 6th of February 2019. The firm had 1:20 split on the 1st of March 2022. Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. Pulmatrix, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts. Pulmatrix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 24 people. To find out more about Pulmatrix contact Teofilo MBA at 781 357 2333 or learn more at https://www.pulmatrix.com.

Pulmatrix Investment Alerts

Pulmatrix Upcoming and Recent Events

Pulmatrix Largest EPS Surprises

View All Earnings Estimates

Pulmatrix Stock Institutional Investors

Note, although Pulmatrix's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Pulmatrix Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.16 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pulmatrix's market, we take the total number of its shares issued and multiply it by Pulmatrix's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Pulmatrix Profitablity

The company has Profit Margin (PM) of (1.93) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.01) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.01.

Management Efficiency

Pulmatrix has return on total asset (ROA) of (0.246) % which means that it has lost $0.246 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5752) %, meaning that it created substantial loss on money invested by shareholders. Pulmatrix's management efficiency ratios could be used to measure how well Pulmatrix manages its routine affairs as well as how well it operates its assets and liabilities. As of the 7th of May 2024, Return On Tangible Assets is likely to drop to -0.44. In addition to that, Return On Capital Employed is likely to drop to -0.52. At this time, Pulmatrix's Total Current Assets are very stable compared to the past year. As of the 7th of May 2024, Net Tangible Assets is likely to grow to about 37.6 M, while Non Current Assets Total are likely to drop about 8.2 M.

Technical Drivers

As of the 7th of May, Pulmatrix holds the Coefficient Of Variation of 1413.38, semi deviation of 2.77, and Risk Adjusted Performance of 0.0529. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pulmatrix, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Pulmatrix, which can be compared to its competitors. Please check Pulmatrix standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and expected short fall to decide if Pulmatrix is priced some-what accurately, providing market reflects its current price of 1.86 per share. Please also confirm Pulmatrix total risk alpha, which is currently at (0.15) to check out the company can sustain itself at a future point.

Pulmatrix Price Movement Analysis

Pulmatrix Insider Trading Activities

Pulmatrix Predictive Daily Indicators

Pulmatrix Forecast Models

Pulmatrix's time-series forecasting models are one of many Pulmatrix's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pulmatrix's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pulmatrix prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pulmatrix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pulmatrix. By using and applying Pulmatrix Stock analysis, traders can create a robust methodology for identifying Pulmatrix entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pulmatrix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pulmatrix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Pulmatrix stock analysis indicators help investors evaluate how Pulmatrix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pulmatrix shares will generate the highest return on investment. By understating and applying Pulmatrix stock analysis, traders can identify Pulmatrix position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulmatrix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

When running Pulmatrix's price analysis, check to measure Pulmatrix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulmatrix is operating at the current time. Most of Pulmatrix's value examination focuses on studying past and present price action to predict the probability of Pulmatrix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulmatrix's price. Additionally, you may evaluate how the addition of Pulmatrix to your portfolios can decrease your overall portfolio volatility.

Is Pulmatrix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmatrix. If investors know Pulmatrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmatrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Pulmatrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmatrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmatrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.